How to use Equipoise?The intended use was in the horse and cattle industry. In general, EQ comes in an oil suspension that can be injected into animals every 6 weeks. There are no legitimate version of boldenone undecylenate approved by any government anywhere equipoise injection the world for human equipoise injection. All of nijection Equipoise on the market injevtion either from approved veterinarian labs or made in an underground laboratories meant for the black market. Even though it is equipoise injection as veterinarian steroid, boldenone is quite powerful when used by humans. What is Equipoise Boldenone Undecylenate?
Equipoise - online-casino-player.info
The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content. Boldenone undecylenate is a steroid ester possessing marked anabolic properties and a small amount of androgenic activity.
Anabolic and androgenic agents have come to be widely used in the treatment of certain pathophysiological or catabolic processes in animals. In many instances, it is desirable to maintain a constant level of effect over a long period of time.
Boldenone undecylenate is a long-acting injectable agent which has a rapid onset of action; this is advantageous and is preferred over frequent oral dosing or even repeated injections. Studies conducted in laboratory animals to evaluate pharmacological activity characterized boldenone undecylenate as having distinct anabolic properties together with a certain degree of androgenic activity.
It does not have marked antigonadotrophic properties, nor does it produce any clear-cut effects on the endometrium, conditions that are commonly observed when similar substances are used. In clinical trials at the recommended dosage, EQUIPOISE injectable had a marked anabolic effect in debilitated horses, appetite improved, weight gain was noted, vigor increased and improvement was noted in musculature and haircoat. This would be expected with an anabolic agent such as EQUIPOISE injectable, particularly where there had been marked tissue breakdown associated with disease, prolonged anorexia or overwork.
It is not a substitute for a well-balanced diet. Optimal results can be expected only when good management and feeding practices are utilized. EQUIPOISE injectable should be considered only as adjunctive therapy to other specific and supportive therapy for diseases, surgical cases and traumatic injuries.
The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information - verify here.
Equipoise Injectable Canada This page contains information on Equipoise Injectable for veterinary use. The information provided typically includes the following: Each mL contains 50 mg boldenone undecylenate Preservative: Actions Anabolic agents are related to the sex hormones, but each varies in its anabolic and androgenic effect.
Compounds such as methyltestosterone have anabolic activity, but with prolonged use, animals develop marked androgenic activity which makes these compounds unsuitable for prolonged therapy. Debilitation often follows disease or may occur following overwork and over-exertion.
Warning For horses only. This drug is not to be administered to horses that are to be slaughtered for use in food. Keep out of reach of children. Contraindications In the absence of data on the effect of boldenone undecylenate on immature colts and fillies, stallions, pregnant mares or brood mares during the breeding season, this drug should not be used in these animals. If these effects occur, they may persist for up to 6 to 8 weeks.
No additional injections of boldenone undecylenate should be administered. Should this occur, discontinue treatment until all signs of androgenicity disappear. Treatment may be repeated every 2 to 3 weeks. The condition should be assessed by a veterinarian to determine the duration of treatment; however, most horses will respond with one or two treatments. Wyeth Canada, Marcel Laurin Blvd. Every effort has been made to ensure the accuracy of the Equipoise Injectable information published above.
However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.